Etoricoxib in ankylosing spondylitis: is there a role for active patients refractory to traditional NSAIDs?

Abstract:

OBJECTIVES:To evaluate the efficacy of etoricoxib in patients with axial ankylosing spondyloarthritis (AS) refractory to traditional NSAIDs. METHODS:This was an open label, multicentric, randomised, prospective (4 weeks with and open extension to 6 months), non-controlled study. Consecutive patients with axial AS refractory to traditional NSAID eligible for anti-TNF-α therapy were selected. The primary outcomes were the rate of patients with good clinical response (not eligible for anti-TNF-α therapy after etoricoxib) and the Assessment of Spondyloarthritis International Society response criteria for biologic therapies (ASASBIO) response at 4 weeks. Secondary outcomes included: ASAS20 and 40 responses, ASDAS-CRP response, BASDAI, BASFI, back and night back pain, global patient and physician assessment of the disease, and biologic parameters like C-reactive protein (CRP) at 2, 4 weeks and 6 months. RESULTS:A total of 57 axial AS patients were recruited, 46 men, with mean age of 43 years. After 4 weeks of treatment, 26 patients (46%) achieved a good clinical response and 11 (20%) an ASASBIO response. These results at 24 weeks were 19 (33%) and 13 (23%) respectively. All individual clinical variables improved significantly after 4 weeks of treatment. CRP serum levels decreased after 4 weeks but reached no statistical significance, although 30% of patients showed a normalisation of CRP. CONCLUSIONS:Etoricoxib provided a clear clinical improvement in around a third of patients with axial AS refractory to traditional NSAIDs. Special care should be required when deciding to start anti-TNF-α therapy; it seems reasonable to keep in mind these results of etoricoxib treatment.

journal_name

Clin Exp Rheumatol

authors

Gratacós J,Moreno Martínez-Losa M,Font P,Montilla C,Fernández-Espartero C,Linares LF,Brito E,Oliva JC,Collantes-Estevez E,Etoricoxib Study Group.

subject

Has Abstract

pub_date

2016-01-01 00:00:00

pages

94-9

issue

1

eissn

0392-856X

issn

1593-098X

pii

9508

journal_volume

34

pub_type

杂志文章,多中心研究,随机对照试验
  • Lymph node angiogenesis in lymphoproliferative disorders: type II Mixed cryoglobulinemia as a model.

    abstract:OBJECTIVES:Lymph node biopsies from patients with mixed cryoglobulinemia (MC) were investigated for: a) the presence of the hepatitis C virus (HCV) peptides C22 and C100; b) the degree of angiogenesis and of inflammatory infiltrate (macrophages and neutrophils); c) the distribution of laminin and type IV collagen, the ...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Vacca A,Ribatti D,Fanelli M,Nico B,Di Reda D,Minischetti M,Dammacco F

    更新日期:1995-11-01 00:00:00

  • Factors associated with the decision of the rheumatologist to order sacroiliac joints magnetic resonance imaging (SI-MRI) or HLA-B27 testing in the diagnostic work-up of patients with spondyloarthritis in clinical practice.

    abstract:OBJECTIVES:To evaluate the patients' characteristics associated with the clinical decision to request SI-MRI and/or HLA-B27 in patients with SpA in daily practice. METHODS:Patients referred to a rheumatology outpatient-clinic in a national referral-centre were selected. Patients with a clinical diagnosis of SpA accord...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Bautista-Molano W,Landewé RB,Serna C,Valle-Oñate R,van der Heijde D

    更新日期:2017-01-01 00:00:00

  • Antinuclear antibodies in the general population: positive association with inflammatory and vascular biomarkers but not traditional cardiovascular risk factors.

    abstract:OBJECTIVES:Patients with clinically evident autoimmune disease are at increased risk for premature cardiovascular disease (CVD). Markers of serological autoimmunity such as anti-nuclear antibodies (ANA) are found in approximately 25% of the general population. Yet, the vast majority will not develop clinical autoimmune...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Solow EB,Vongpatanasin W,Skaug B,Karp DR,Ayers C,de Lemos JA

    更新日期:2018-11-01 00:00:00

  • High prevalence of fibromyalgia-associated symptoms in patients with hypothalamic-pituitary disorders.

    abstract:OBJECTIVES:Various complaints of patients with fibromyalgia often resemble clinical features observed in patients with hypothalamic-pituitary diseases. The aim of this study was to evaluate whether patients with hypothalamic-pituitary diseases are at increased risk for fibromyalgia syndrome (FMS). METHODS:A questionna...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Harbeck B,Süfke S,Harten P,Haas CS,Lehnert H,Mönig H

    更新日期:2013-11-01 00:00:00

  • The attachment of certain gram negative bacteria to buccal epithelial cells from patients with Yersinia arthritis.

    abstract::The frequency of attachment of certain members of the Enterobacteriaceae implicated in arthritis to buccal epithelial cells from patients with post-Yersinia reactive arthritis, Yersinia enteritis and from healthy controls was examined using a fluorescent labelling technique. Klebsiella K43 bound significantly more fre...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Robinson S,Panayi GS,Marsal L,Wollheim FA

    更新日期:1983-07-01 00:00:00

  • A comparison of the measurement properties and estimation of minimal important differences of the EQ-5D and SF-6D utility measures in patients with systemic sclerosis.

    abstract:OBJECTIVES:To compare measurement properties of the EQ-5D and SF-6D utility measures, to assess the association and agreement between these measures and to estimate minimal important differences (MID) in patients with systemic sclerosis (SSc). METHODS:Both measures were assessed twice in an observational prospective d...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Kwakkenbos L,Fransen J,Vonk MC,Becker ES,Jeurissen M,van den Hoogen FH,van den Ende CH

    更新日期:2013-03-01 00:00:00

  • Histologic assessment of cathepsin D in osteoarthritic cartilage.

    abstract::The lysosomal endopeptidase cathepsin D is the most abundant proteinase in chondrocytes. Its significance in the pathogenesis of cartilage matrix proteoglycan (PG) degradation in osteoarthritis (OA) is unclear. The extracellular localization of cathepsin D and its potential spatial relationship to areas of PG depletio...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Vittorio N,Crissman JD,Hopson CN,Herman JH

    更新日期:1986-07-01 00:00:00

  • Awareness and knowledge of fibromyalgia among French rheumatologists and general practitioners.

    abstract:OBJECTIVES:Fibromyalgia is a chronic disorder characterized by widespread musculoskeletal pain and fatigue. Its prevalence is estimated to be at 3.4% in women and 0.5% in men. It is a major cause of morbidity. Our objective was to evaluate, using a self-questionnaire sent by mail, the level of knowledge of French physi...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Blotman F,Thomas E,Myon E,Andre E,Caubere JP,Taïeb C

    更新日期:2005-09-01 00:00:00

  • Serum aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1), a novel disease activity predictive biomarker of systemic lupus erythematosus.

    abstract:OBJECTIVES:Secreted aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) has been reported to have pro-inflammatory properties. The aim of this study was to evaluate the clinical significance of serum AIMP1 in patients with systemic lupus erythematosus (SLE). METHODS:Serum levels of AIMP1 were measu...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Ahn SS,Hong SH,Park Y,Jung SM,Song JJ,Park YB,Lee SW,Park SG

    更新日期:2018-07-01 00:00:00

  • Epilepsy in systemic lupus erythematosus.

    abstract::Systemic lupus erythematosus (SLE) is an autoimmune systemic disease characterised by a broad spectrum of clinical manifestations that may also affect the central nervous system. Among the neurological symptoms, seizures were included in the criteria for the classification of SLE published by EULAR/ACR in 2019. Severa...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,评审

    doi:

    authors: Grasso EA,Cacciatore M,Gentile C,Breda L,Giacomelli R,Verrotti A

    更新日期:2020-09-04 00:00:00

  • High LDL-C levels attenuate onset of inflammation and cartilage destruction in antigen-induced arthritis.

    abstract:OBJECTIVES:In this study, we used hypercholesterolaemic apolipoprotein E-deficient (Apoe-/-) mice to investigate LDL/oxLDL effect on synovial inflammation and cartilage destruction during antigen-induced arthritis (AIA). Further, as macrophage FcγRs are crucial to immune complex-mediated AIA, we investigated in vitro t...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Ascone G,Di Ceglie I,van den Bosch MHJ,Kruisbergen NNL,Walgreen B,Sloetjes AW,Lindhout E,Joosten LAB,van de Loo FAJ,Koenders MI,van der Kraan PM,Blom AB,van Lent PLEM

    更新日期:2019-11-01 00:00:00

  • Glycosaminoglycans in autoimmunity.

    abstract::Alteration of the distribution pattern and composition of glycosaminoglycans (GAG) and proteoglycans may play an important role in the development of autoimmune diseases. Recent experiments indicate that anti-DNA antibodies cross-reacting with hyaluronic acid, heparan sulphate and chondroitin sulphate are present in p...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,评审

    doi:

    authors: Hansen C,Otto E,Kuhlemann K,Förster G,Kahaly GJ

    更新日期:1996-05-01 00:00:00

  • COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?

    abstract::A severe outbreak of coronavirus disease 2019 (COVID-19) emerged in China in December 2019, and spread so rapidly that more than 200,000 cases have so far been reported worldwide; on January 30, 2020, the WHO declared it the sixth public health emergency of international concern. The two previously reported coronaviru...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,评审

    doi:

    authors: Sarzi-Puttini P,Giorgi V,Sirotti S,Marotto D,Ardizzone S,Rizzardini G,Antinori S,Galli M

    更新日期:2020-03-01 00:00:00

  • Rheumatoid arthritis and ankylosing spondylitis - pathology of acute inflammation.

    abstract::Histomorphological analysis of inflammatory lesions in rheumatoid arthritis (RA) and ankylosing spondylitis (AS) display similarities but also major differences. Ankylosing spondylitis is characterised by two key pathological findings: sacroiliac joint and spinal inflammation and new bone formation with the possible c...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Appel H,Loddenkemper C,Miossec P

    更新日期:2009-07-01 00:00:00

  • Genome-wide analysis of histone H3 lysine 4 trimethylation by ChIP-chip in peripheral blood mononuclear cells of systemic lupus erythematosus patients.

    abstract:OBJECTIVES:Histone H3 lysine 4 trimethylation(H3K4me3) is an important epigenetic modification and associated with active transcription in multiple organisms. In systemic lupus erythematosus (SLE), global and gene-specific DNA methylation changes have been demonstrated to occur. However, to date, our knowledge about th...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Dai Y,Zhang L,Hu C,Zhang Y

    更新日期:2010-03-01 00:00:00

  • Felty's syndrome without concomitant arthritis: a variant.

    abstract::A young female patient who had documented seropositive rheumatoid arthritis and was treated consecutively with aspirin, diclofenac, and gold salts was admitted years later for severe neutropenia. On examination she had, in addition, fever, positive rheumatoid factor, reversible swan-neck deformity of the fingers but o...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Cycowitz Z,Heller I,Burke M,Vardinon N,Yust I

    更新日期:1989-05-01 00:00:00

  • Activated T lymphocytes in the peripheral blood of patients with systemic lupus erythematosus induce B cells to produce immunoglobulin.

    abstract::Systemic lupus erythematosus (SLE) is characterized by multiple T and B cell abnormalities. This study was designed to investigate the cell surface membrane characteristics of T cells by using single and double immunofluorescence and examine the role of HLA-DR+ T cells in the production of immunoglobulin by B cells. T...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Inghirami G,Simon J,Balow JE,Tsokos GC

    更新日期:1988-07-01 00:00:00

  • Elevated IgG autoantibody production in oligoarticular juvenile idiopathic arthritis may predict a refractory course.

    abstract:OBJECTIVES:Although oligoarticular juvenile idiopathic arthritis (oJIA) is considered to carry the best prognosis among the JIA subtypes, many children evolve to a chronic course. A few studies have identified clinical risk factors for disease extension, and recent studies have evaluated synovial fluid markers. However...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Stoll ML,Li QZ,Zhou J,Punaro M,Olsen NJ

    更新日期:2011-07-01 00:00:00

  • Benign monoclonal gammopathy with IgG anti-DNA, anti-Sm and anti-F(ab')2 activity.

    abstract:OBJECTIVE:To study anti-DNA idiotypic markers and anti-DNA activity in human monoclonal immunoglobulin proteins. METHODS:Seventy human IgG M-components intentionally selected for cationic electrophoretic characteristics were studied for F4 and 31 anti-DNA idiotypic markers and anti-DNA as well as anti-F(ab')2 antibody...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Williams RC Jr,Malone CC,Silvestris F,Nickerson KG

    更新日期:1997-01-01 00:00:00

  • Recommendations in clinical practice guidelines on gout: systematic review and consistency analysis.

    abstract:OBJECTIVES:To compare and analyse the recommendations from clinical practice guidelines (CPGs) on gout worldwide, examine the consistency across CPGs, and provide suggestions to develop and update gout guidelines. METHODS:We conducted systematic searches in MEDLINE, CBM, GIN, NICE, NGC, WHO, SIGN, DynaMed, UpToDate, a...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Yu Y,Wang D,Zhou Q,Wang C,Ma X,Gao Y,Song X,Xiao S,Wang Q,Zeng X,Estill J,Qian Z,Chen Y

    更新日期:2020-09-01 00:00:00

  • A probability score to aid the diagnosis of suspected giant cell arteritis.

    abstract:OBJECTIVES:We propose a GCA probability score intended to help to risk-stratify patients referred by general practitioners with suspected GCA into those with high probability of GCA versus low probability of GCA. In this pilot study we evaluated the diagnostic accuracy of this proposed scoring system. METHODS:A scorin...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Laskou F,Coath F,Mackie SL,Banerjee S,Aung T,Dasgupta B

    更新日期:2019-03-01 00:00:00

  • Short-term adalimumab therapy improves endo-thelial function in patients with rheumatoid arthritis refractory to infliximab.

    abstract:OBJECTIVE:Endothelial dysfunction has been found in patients with rheumatoid arthritis (RA). In this study we aimed to assess whether adalimumab, a fully human monoclonal antibody directed against TNF-alpha, was able to improve endothelial function in RA patients with long-standing disease refractory to infliximab. ME...

    journal_title:Clinical and experimental rheumatology

    pub_type: 临床试验,杂志文章

    doi:

    authors: Gonzalez-Juanatey C,Llorca J,Sanchez-Andrade A,Garcia-Porrua C,Martin J,Gonzalez-Gay MA

    更新日期:2006-05-01 00:00:00

  • Alteration of oral flora in Mongolian patients with Behçet's disease: a multicentre study.

    abstract:OBJECTIVES:Behçet's disease (BD) is characterised by repeated acute inflammatory attacks with aphthous ulcers of the oral mucosa, uveitis of the eyes, skin symptoms, and genital ulcers. Although its aetiology is still unknown, there is evidence of the involvement of oral bacteria in systemic diseases. Various types of ...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Balt J,Uehara O,Abiko Y,Jamyanjav B,Jav S,Nagasawa T,Mori M,Horie Y,Fujita M,Lennikov A,Ohta T,Hiraoka M,Iwata D,Namba K,Ohno S,Kitaichi N

    更新日期:2020-09-01 00:00:00

  • Tocilizumab in the treatment of patients with rheumatoid arthritis in real clinical practice: results of an Italian observational study.

    abstract:OBJECTIVES:To describe the effectiveness and safety of tocilizumab (TCZ), an interleukin-6 receptor inhibitor, in a cohort of patients with rheumatoid arthritis (RA) recruited in clinical practice. METHODS:TRUST was an observational study in RA patients who started treatment with TCZ in the 6 months prior to site acti...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Caporali R,Idolazzi L,Bombardieri S,Ferraccioli G,Gerli R,Govoni M,Matucci Cerinic M,Pomponio G,Salaffi F,Tirri R,Benaglio F,Bianchino L,Sarzi-Puttini P,TRUST study investigators.

    更新日期:2017-11-01 00:00:00

  • COX-2 inhibitors and the kidney.

    abstract::Cyclooxygenase-2 (COX-2) selective inhibitors are now extensively used for their anti-inflammatory and analgesic efficacy. Several large controlled trials provide evidence to support the proposition that they cause fewer major gastro-intestinal side effects and less toxicity than routine nonsteroidal anti-inflammatory...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Appel GB

    更新日期:2001-11-01 00:00:00

  • Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil.

    abstract:OBJECTIVE:Skin disease can be one of the most refractory clinical manifestations of systemic lupus erythematosus (SLE). The standard therapy consists of sunscreens, topical corticosteroids and antimalarials. However in difficult cases a variety of other drugs have been tried. Here we describe our clinical experience wi...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Pisoni CN,Obermoser G,Cuadrado MJ,Sanchez FJ,Karim Y,Sepp NT,Khamashta MA,Hughes GR

    更新日期:2005-05-01 00:00:00

  • The Schnitzler syndrome: chronic urticaria in disguise: a single-centre report of 11 cases and a critical reappraisal of the literature.

    abstract:OBJECTIVES:The Schnitzler syndrome is a rare inflammatory disorder, with a chronic urticaria-like rash and an IgM (rarely IgG) monoclonal gammopathy as cardinal features. Interleukin-1 β is regarded as the key mediator and the interleukin-1 receptor antagonist anakinra has been proposed as first-line treatment. This ca...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Vanderschueren S,van der Veen A

    更新日期:2017-01-01 00:00:00

  • Anti-GOR antibodies, HCV, liver disease and cryoglobulinemia.

    abstract:OBJECTIVE:We investigated the presence of anti-GOR antibodies in patients with essential mixed cryoglobulinemia, since both autoimmune pathogenetic processes and a high prevalence of HCV infection are present in this syndrome. METHODS:We compared these cases to patients with HCV-related chronic active hepatitis or alc...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Saccardo F,Monti G,Rinaldi G,Pioltelli P,Mosconi L,Garelli G

    更新日期:1995-11-01 00:00:00

  • Results of a questionnaire on the treatment of patients with Behçet's syndrome: a trend for more intensive treatment.

    abstract:OBJECTIVES:To determine the preferred treatment for patients with Behçet's syndrome. METHODS:A questionnaire was given to all participants of the 2010 meeting of the International Society for Behçet's Disease. RESULTS:Forty-one respondents from 6 different subspecialties. In the case of a patient with (severe) poster...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Turkstra F,van Vugt RM,Dijkmans BA,Yazici Y,Yazici H

    更新日期:2012-05-01 00:00:00

  • The APOM polymorphism as a novel risk factor for dyslipidaemia in rheumatoid arthritis: a possible shared link between disease susceptibility and dyslipidaemia.

    abstract:OBJECTIVES:A decrease in high-density lipoprotein (HDL) cholesterol during inflammation is common in many rheumatologic diseases, including rheumatoid arthritis (RA). Apolipoprotein M (apoM) is an apolipoprotein predominantly associated with HDL cholesterol. Recently, apoM polymorphisms have been related with RA suscep...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Park YJ,Yoo SA,Lee JH,Chung YJ,Cho CS,Kim W-

    更新日期:2013-03-01 00:00:00